Opaleye Management Inc. Q4 2021 Filing

Filed February 14, 2022

Portfolio Value

$471.5M

Holdings

39

Report Date

Q4 2021

Filing Type

13F-HR

All Holdings (39 positions)

#StockSharesValue% PortfolioType
1
CDXSCODEXIS INC
1,345,000$42.1M8.92%
2
OCULOCULAR THERAPEUTIX INC
5,974,800$41.6M8.83%
3
CMRXEURCHIMERIX INC
5,580,000$35.9M7.61%
4
TCE2CELLDEX THERAPEUTICS INC
844,000$32.6M6.92%
5
HROWHARROW HEALTH INC
3,285,000$28.4M6.02%
6
CYTKCYTOKINETICS INC
580,000$26.4M5.61%
7
CRNXCRINETICS PHARMACEUTICALS INC
724,400$20.6M4.36%
8
TARAPROTARA THERAPEUTICS INC
2,650,000$18.0M3.82%
9
SMLRSEMLER SCIENTIFIC INC
172,000$15.8M3.34%
10
RJR1STEREOTAXIS INC
2,526,500$15.7M3.32%
11
KROSKEROS THERAPEUTICS INC
265,750$15.5M3.30%
12
KNSAKINIKSA PHARMACEUTICALS LTD
1,025,000$12.1M2.56%
13
PTGXPROTAGONIST THERAPEUTICS INC
342,000$11.7M2.48%
14
PRQRPROQR THERAPEUTICS NV
1,435,510$11.5M2.44%
15
ETONETON PHARMACEUTICALS INC
2,385,000$10.2M2.17%
16
STROSUTRO BIOPHARMA INC
680,000$10.1M2.15%
17
MRUSMERUS N.V.
317,800$10.1M2.14%
18
LRMRLARIMAR THERAPEUTICS INC
883,602$9.5M2.02%
19
FORTRESS BIOTECH INC
3,750,000$9.4M1.99%
20
RETAEURREATA PHARMACEUTICALS INC
330,000$8.7M1.85%
21
TCONTRACON PHARMACEUTICALS INC
3,055,000$8.5M1.79%
22
DNAGINKGO BIOWORKS HOLDINGS INC
929,780$7.7M1.64%
23
PCVXVAXCYTE INC
315,800$7.5M1.59%
24
MGNXMACROGENICS INC
462,000$7.4M1.57%
25
XOMAXOMA CORP DEL
338,350$7.1M1.50%
26
TELATELA BIO INC
449,867$5.8M1.22%
27
HYPRHYPERFINE INC
763,075$5.5M1.17%
28
BBIOBRIDGEBIO PHARMA INC
328,100$5.5M1.16%
29
NEOLEUKIN THERAPEUTICS INC
1,047,300$5.0M1.07%
30
FDMT4D MOLECULAR THERAPEUTICS INC
229,000$5.0M1.07%
31
VSTMVERASTEM INC
2,325,000$4.8M1.01%
32
SIERRA ONCOLOGY INC
165,778$3.6M0.76%
33
MEIPUSDMEI PHARMA INC
1,315,000$3.5M0.74%
34
NUCANA PLC
1,189,000$2.8M0.60%
35
AVALO THERAPEUTICS INC
1,459,400$2.5M0.53%
36
SYNLOGIC INC
850,000$2.1M0.44%
37
0HJQAVEO BIOSCIENCES INC
263,400$1.2M0.26%
38
LQDALIQUIDIA CORPORATION
16,800$82K0.02%
39
BIOLINERX LTD
16,667$34K0.01%